Dose-response study of topical minoxidil in male pattern alopecia.

doi:10.1016/S0190-9622(87)70086-3

Paper

Dose-response study of topical minoxidil in male pattern alopecia.

Published Mar 1, 1987 · J. Shupack, J. J. Kassimir, T. Thirumoorthy

Journal of the American Academy of Dermatology

Q1 SJR score

26

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Study Snapshot

Topical minoxidil at 0.1% and higher doses significantly increases nonvellus hair growth, but only at 1% and 2% doses is clinically perceptible hair growth observed in male pattern baldness patients.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Dose-response study of topical minoxidil in male pattern alopecia.

Sign up to use Study Snapshot

References

Topical minoxidil in early male pattern baldness.

Topical minoxidil can significantly increase terminal hair growth in early male pattern baldness compared to placebo.

Topical minoxidil therapy in hereditary androgenetic alopecia.

Topical minoxidil therapy can achieve cosmetically acceptable hair growth in 32% of patients with hereditary male pattern baldness, without serious systemic or cutaneous side effects.

PATTERNED LOSS OF HAIR IN MAN: TYPES AND INCIDENCE

This study aims to establish types of scalp hairiness, survey their incidence, and determine their relationship with genetic, age, and endocrine factors.

Citations

Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.

Dutasteride and minoxidil show the greatest efficacy in increasing total hair count and terminal hair count, respectively, for male androgenetic alopecia treatment.

Minoxidil: a comprehensive review

Topical minoxidil effectively promotes hair regrowth in androgenetic alopecia for both men and women, with oral and sublingual forms showing potential for greater efficacy.

Propylene glycol free 5% minoxidil lotion formulation: cosmetic acceptability, local tolerability, clinical efficacy and in-vitro skin absorption evaluations.

The new propylene glycol-free 5% minoxidil lotion shows high cosmetic acceptability and tolerability, with comparable clinical efficacy and skin penetration compared to the PG-based lotion.

Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality

Newer treatments like low-level laser therapy may be more effective than traditional therapies like 5% minoxidil for treating androgenetic alopecia in men and women, but their efficacy needs further validation through future randomized controlled trials.

Drugs Affecting Hair Growth

Hair growth is influenced by various drugs, including testosterone, dihydrotestosterone, androgen, and various hormones, which can be used to treat hair loss and promote hair growth.